Tengjun Biotechnology (TJBH) 10-Q 22 Apr 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Apr. 22, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	Tengjun Biotechnology Corp.
Entity Central Index Key	0001499785
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Filer Number	333-169397
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	NV
Entity Common Stock, Shares Outstanding		45,716,580

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash and cash equivalents
Prepaid expenses	13,137	4,299
TOTAL CURRENT ASSETS	13,137	4,299
TOTAL ASSETS	13,137	4,299
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	11,100	11,125
Related party loans	290,623	272,814
TOTAL CURRENT LIABILITIES	301,723	283,939
STOCKHOLDERS' DEFICIT:
Preferred stock ($.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding)
Common stock ($.001 par value; 70,000,000 shares authorized; 43,216,580 and 43,136,540 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively)	43,217	43,137
Additional paid-in capital	208,859	201,095
Accumulated deficit	(540,662)	(523,872)
TOTAL STOCKHOLDERS' DEFICIT	(288,586)	(279,640)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 13,137	$ 4,299

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	43,216,580	43,136,540
Common stock, shares outstanding	43,216,580	43,136,540

Unaudited Condensed Statements

Unaudited Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenues
Operating Expenses:
Accounting fees	6,300	6,125
Other general and administrative	5,051	4,615
Total Operating Expenses	11,351	10,740
Loss from Operations	(11,351)	(10,740)
Other Expense:
Interest expense - related party	(5,439)	(4,724)
Total Other Expense	(5,439)	(4,724)
Net Loss	$ (16,790)	$ (15,464)
Net loss per common share, basic and diluted	$ 0	$ 0
Weighted average number of common shares outstanding:
Basic and diluted	43,198,109	38,136,540

Unaudited Condensed Statement_2

Unaudited Condensed Statements of Changes In Stockholders' Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 38,137	$ 180,723	$ (464,007)	$ (245,147)
Balance, shares at Dec. 31, 2018	38,136,540
Imputed interest		4,724		4,724
Net loss			(15,464)	(15,464)
Balance at Mar. 31, 2019	$ 38,137	185,447	(479,471)	(255,887)
Balance, shares at Mar. 31, 2019	38,136,540
Balance at Dec. 31, 2019	$ 43,137	201,095	(523,872)	(279,640)
Balance, shares at Dec. 31, 2019	43,136,540
Common stock sold for cash	$ 80	2,325		2,405
Common stock sold for cash, shares	80,040
Imputed interest		5,439		5,439
Net loss			(16,790)	(16,790)
Balance at Mar. 31, 2020	$ 43,217	$ 208,859	$ (540,662)	$ (288,586)
Balance, shares at Mar. 31, 2020	43,216,580

Unaudited Condedsed Statements

Unaudited Condedsed Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (16,790)	$ (15,464)
Adjustments to reconcile net loss to net cash used in operating activities:
Imputed interest on related party loans	5,439	4,724
Changes in operating assets and liabilities:
Increase in prepaid expenses	(8,838)	(9,000)
Decrease in accounts payable and accrued liabilities	(25)	(25)
NET CASH USED IN OPERATING ACTIVITIES	(20,214)	(19,765)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds received from related party loans	20,214	19,765
Proceeds from sale of common stock	2,405
Repayment made for related party loans	(2,405)
NET CASH PROVIDED BY FINANCING ACTIVITIES	20,214	19,765
NET INCREASE IN CASH
Cash, beginning of period
Cash, end of period
SUPPLEMENTAL DISCLOSURES:
Interest paid
Income taxes paid

Organization

Organization	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	NOTE 1 - Organization China Herb Group Holdings Corporation (the "Company") was incorporated under the name "Island Radio, Inc" under the laws of the State of Nevada on June 28, 2010. On December 9, 2019, the Company changed its corporate name to Tengjun Biotechnology Corp. On June 27, 2012, Eric R. Boyer and Nina Edstrom (collectively, the "Sellers"), who were then the major shareholders of the Company, entered into a Share Purchase Agreement with Chin Yung Kong, Qiuping Lu and Fumin Feng (collectively, the "Purchasers"), pursuant to which the Sellers sold to the Purchasers an aggregate 4,000,000 shares of the common stock of the Company, which represented approximately 93% of the then total issued and outstanding stock of the Company, for a total purchase price of $159,970 (the "Change in Control"). As result of this share purchase transaction, Chin Yung Kong, Qiuping Lu and Fumin Feng became the controlling shareholders of the Company. The Company's original business plan was to become a commercial FM radio broadcaster. Subsequently, following the Change in Control, the Company changed its business plan and intended to become a medical and spa company with a focus on Asia. However, after consultation with its professional and business advisors in the United States and the People's Republic of China, the Company's management decided during the third quarter of 2014 that this would no longer be its plan of operations. The Company's plan of operations is to evaluate various industries, geographic and market opportunities. This may take the form of acquiring a business, being acquired by an existing business or developing a business organically. Any such efforts may require significant capital, which the Company currently lacks. There is no assurance that any such opportunity will become available. There is also no assurance that, if any opportunity becomes available, the Company will have the financial and other resources available to take advantage of such opportunity, since the Company has extremely limited liquidity. Through March 31, 2020, the Company has no revenues or operation.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 - Summary of Significant Accounting Policies Unaudited Interim Financial Information The accompanying balance sheets as of March 31, 2020, statements of operations for the three months ended March 31, 2020 and 2019, statements of changes in stockholders' deficit for the three months ended March 31, 2020 and 2019, and the statements of cash flows for the three months ended March 31, 2020 and 2019, are unaudited. These unaudited interim financial statements have been prepared in accordance with accounting principles accepted in the United States of America ("U.S. GAAP"). In the opinion of the Company's management, the unaudited interim financial statements have been prepared on the same basis as the audited financial statements and included all adjustments necessary for the fair presentation of the Company's statement of financial position at March 31, 2020 and its results of operations and its cash flows for the period ended March 31, 2020. The results for the period ended March 31, 2020 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2020. Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. GAAP for financial information and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission (the "SEC"). They reflect all adjustments which are, in the opinion of the Company's management, necessary for a fair presentation of the financial position as of March 31, 2020 and operating results for the three months ended March 31, 2020 and 2019. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K, for the year ended December 31, 2019, filed with the SEC on February 28, 2020. Use of Estimates The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates. Fair Value of Financial Instruments ASC 820, "Fair Value Measurements" and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities As of March 31, 2020 and December 31, 2019, the Company believes that the recorded values of all of its financial instruments approximate their current fair values because of their nature and respective maturity dates or durations Description Level 1 Level 2 Level 3 Total Realized Loss March 31, 2020 - - - - December 31, 2019 - - - - ASC 825-10 "Financial Instruments", allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments. Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of March 31, 2020 and December 31, 2019, the Company had no cash equivalents. Prepaid Expenses Prepaid expenses relate to cash paid in advance for annual listing fee and business license. These amounts are recognized as expense over the related listing and service periods. At March 31, 2020 and December 31, 2019, prepaid expenses amounted $13,137 and $4,299, respectively. Income Taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company follows the provisions of Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 740-10 "Uncertainty in Income Taxes" (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a "more-likely-than-not" threshold. As of March 31, 2020 and December 31, 2019, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements. Loss per Share Calculation Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the three months ended March 31, 2020 and 2019, the Company had no dilutive financial instruments issued or outstanding. Recent Accounting Pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2020
Going Concern [Abstract]
Going Concern	NOTE 3 - Going Concern The Company has minimal operations, and as such has devoted most of its efforts since its inception to developing its business plan, issuing common stock, attempting to raise capital, establishing its accounting systems and other administrative functions. As of March 31, 2020, the Company had $0 in cash and has been funding its working capital needs from loans from related party. The Company is seeking sources of funding. Without limiting its available options, future equity financings will most likely be through the sale of additional shares of its common stock. It is possible that the Company could also offer warrants, options and/or rights in conjunction with any future issuances of its common stock. However, the Company can give no assurance that financing will be available to it, and if available, in amounts or on terms acceptable to the Company. The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established a source of revenues sufficient to cover its operating costs, and as such, has incurred an operating loss since its inception. Further, as of March 31, 2020, the Company had a working capital deficit, accumulated deficit and stockholders' deficit of $288,586, $540,662 and $288,586, respectively. These and other factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments or classifications that may result from the possible inability of the Company to continue as a going concern.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 4 - Related Party Transactions Related Party Loans Qiuping Lu, President, CEO, director and shareholder of the Company, advanced funds to the Company for working capital purposes. These working capital advances are payable on demand. As of March 31, 2020 and December 31, 2019, these working capital advances amounted to $290,623 and $272,814, respectively, are reflected as related party loans on the accompanying balance sheets. During the three months ended March 31, 2020 and 2019, in connection with these related party loans, the Company imputed interest of $5,439 and $4,724, respectively, and recorded interest expense and an increase in additional paid-in capital. During the quarter ended March 31, 2020, the Company sold 80,040 shares of common stock for $2,405. As the Company did not have a bank account, the funds were deposited directly to Ms. Lu's personal bank account and was accounted for as a repayment for advances outstanding made by Ms. Lu. Office Space from Related Party The Company uses office space of a related party, free of rent, which is considered immaterial.

Stockholders_ Deficit

Stockholders’ Deficit	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Stockholders’ Deficit	NOTE 5 – Stockholders' Deficit Preferred Stock The total number of preferred shares authorized that may be issued by the Company is 5,000,000 shares with a par value of $0.001 per share. As of March 31, 2020 and December 31, 2019, the Company had no shares of its preferred stock issued and outstanding. Common Stock The total number of common shares authorized that may be issued by the Company is 70,000,000 shares with a par value of $0.001 per share. As of March 31, 2020 and December 31, 2019, the Company had 43,216,580 and 43,136,540 shares of its common stock issued and outstanding, respectively. Common Stock Sold for Cash On January 22, 2020, the Company sold 80,040 shares of common stock at a purchase price of $0.03 per share to seven investors pursuant to stock purchase agreements. The Company did not engage a placement agent with respect to the sale. The Company received proceeds of $2,405.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 6 – Commitments and Contingencies At March 31, 2020, there were no legal proceedings against the Company.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 7 – Subsequent Events On April 7, 2020 , the Company sold 2,500,000 shares of common stock at a purchase price of $0.01 per share to an investor pursuant to a stock purchase agreement. The Company did not engage a placement agent with respect to the sale. The Company received

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Unaudited Interim Financial Information	Unaudited Interim Financial Information The accompanying balance sheets as of March 31, 2020, statements of operations for the three months ended March 31, 2020 and 2019, statements of changes in stockholders' deficit for the three months ended March 31, 2020 and 2019, and the statements of cash flows for the three months ended March 31, 2020 and 2019, are unaudited. These unaudited interim financial statements have been prepared in accordance with accounting principles accepted in the United States of America ("U.S. GAAP"). In the opinion of the Company's management, the unaudited interim financial statements have been prepared on the same basis as the audited financial statements and included all adjustments necessary for the fair presentation of the Company's statement of financial position at March 31, 2020 and its results of operations and its cash flows for the period ended March 31, 2020. The results for the period ended March 31, 2020 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2020.
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. GAAP for financial information and in accordance with Regulation S-X promulgated by the Securities and Exchange Commission (the "SEC"). They reflect all adjustments which are, in the opinion of the Company's management, necessary for a fair presentation of the financial position as of March 31, 2020 and operating results for the three months ended March 31, 2020 and 2019. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K, for the year ended December 31, 2019, filed with the SEC on February 28, 2020.
Use of Estimates	Use of Estimates The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC 820, "Fair Value Measurements" and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities As of March 31, 2020 and December 31, 2019, the Company believes that the recorded values of all of its financial instruments approximate their current fair values because of their nature and respective maturity dates or durations Description Level 1 Level 2 Level 3 Total Realized Loss March 31, 2020 - - - - December 31, 2019 - - - - ASC 825-10 "Financial Instruments", allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of March 31, 2020 and December 31, 2019, the Company had no cash equivalents.
Prepaid Expenses	Prepaid Expenses Prepaid expenses relate to cash paid in advance for annual listing fee and business license. These amounts are recognized as expense over the related listing and service periods. At March 31, 2020 and December 31, 2019, prepaid expenses amounted $13,137 and $4,299, respectively.
Income Taxes	Income Taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company follows the provisions of Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 740-10 "Uncertainty in Income Taxes" (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a "more-likely-than-not" threshold. As of March 31, 2020 and December 31, 2019, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements.
Loss per Share Calculation	Loss per Share Calculation Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the three months ended March 31, 2020 and 2019, the Company had no dilutive financial instruments issued or outstanding.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Schedule of financial instruments current fair values	Description Level 1 Level 2 Level 3 Total Realized Loss March 31, 2020 - - - - December 31, 2019 - - - -

Organization (Details)

Organization (Details) - USD ($)	Jun. 27, 2012	Mar. 31, 2020
Organization (Textual)
Sellers sold to purchasers an aggregate shares of common stock	4,000,000
Percentage of company common stock issued and outstanding	93.00%
Total purchase price	$ 159,970	$ 2,405

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Realized Loss

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details Textual) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Summary of Significant Accounting Policies (Textual)
Cash equivalents
Prepaid expenses	$ 13,137	$ 4,299

Going Concern (Details)

Going Concern (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Going Concern (Textual)
Cash
Working capital deficit	288,586
Accumulated deficit	(540,662)	(523,872)
Stockholders' deficit	$ (288,586)	$ (279,640)	$ (255,887)	$ (245,147)

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Related Party Transactions (Textual)
Working capital advances	$ 290,623		$ 272,814
Imputed interest	$ 5,439	$ 4,724
Common stock	80,040
Common stock amount	$ 2,405

Stockholders_ Deficit (Details)

Stockholders’ Deficit (Details)	1 Months Ended
	Jan. 22, 2020USD ($)Investor$ / sharesshares	Mar. 31, 2020$ / sharesshares	Dec. 31, 2019$ / sharesshares
Stockholders’ Deficit (Textual)
Preferred stock, shares authorized		5,000,000	5,000,000
Preferred stock, par value | $ / shares		$ 0.001	$ 0.001
Preferred stock, shares issued		0	0
Preferred stock, shares outstanding		0	0
Common stock, shares authorized		70,000,000	70,000,000
Common stock, par value | $ / shares		$ 0.001	$ 0.001
Common stock, shares issued		43,216,580	43,136,540
Common stock, shares outstanding		43,216,580	43,136,540
Investors [Member]
Stockholders’ Deficit (Textual)
Number of sold shares of common stock	80,040
Purchase price per share | $ / shares	$ 0.03
Proceeds received from sale of common stock | $	$ 2,405
Number of investors | Investor	7

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Apr. 07, 2020	Jun. 27, 2012	Mar. 31, 2020	Mar. 31, 2019
Subsequent Events (Textual)
Common stock sold to several		4,000,000
Proceeds of common stock			$ 2,405
Subsequent Event [Member]
Subsequent Events (Textual)
Common stock sold to several	2,500,000
Common stock at purchase price per share	$ 0.01
Proceeds of common stock	$ 25,000